4baseCare Raises ₹1.3B in Series B Funding

The precision-oncology business is extending its hospital-linked laboratory network and developing OncoTwin for treatment decisions across underrepresented patient populations.

Round size
₹1.3B
Stage
Series B
Headquarters
India
Announced
Jan 27, 2026

Genomic evidence for cancer care

OncoTwin connects a patient’s clinical and genomic profile with real-world treatment and outcomes data. Clinicians can examine similar patient histories and evidence when considering therapies, while the laboratory network brings genomic testing into hospital care.

One Series B, completed in stages

The January announcement disclosed a ₹90 crore first close. Subsequent financing brought in Infosys and growX Ventures alongside existing backers; the company reports the completed round at about ₹130 crore ($14 million). Capital supports laboratories in additional international markets and development of the oncology platform.

Sources

  1. 4baseCare: funding announcement
  2. 4baseCare: genomic testing and clinical products
  3. 4baseCare: OncoTwin clinical and genomic evidence
  4. 4baseCare: final SeriesB financing announcement
  5. BioSpectrum: further SeriesB close, not a new round
  6. C-CAMP: initial and subsequent SeriesB closes
03 / Related rounds

Related funding rounds

01
Series B · Cybersecurity

Upwind

Upwind secures cloud applications by monitoring running workloads and correlating process, network, container and identity data to identify reachable vulnerabilities and attack paths.

Led by Bessemer Venture Partners
$250M
02
Series B · Defense

Harmattan AI

Harmattan AI develops autonomous defense systems for reconnaissance, drone interception, electronic warfare and command and control.

Led by Dassault Aviation
$200M
03
Series B · Aerospace

JetZero

JetZero is developing an all-wing commercial aircraft that blends the passenger cabin and wing into one airframe to improve aerodynamic and fuel efficiency.

Led by B Capital
$175M